Risk Factors for Subclinical Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus. 2024

Li Gao, and Jiexing Qin, and Ying Chen, and Wenqun Jiang, and Desheng Zhu, and Xiajun Zhou, and Jie Ding, and Huiying Qiu, and Yan Zhou, and Qing Dong, and Yangtai Guan
Department of Neurology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.

To investigate the risk factors associated with subclinical diabetic peripheral neuropathy (sDPN) in patients with type 2 diabetes mellitus (T2DM). This cross-sectional, retrospective study involved 311 patients with T2DM who were successively admitted from January 2018 to December 2021 without any neurological symptoms. All participants underwent a nerve conduction study (NCS), and those asymptomatic patients with abnormal nerve conduction were diagnosed with sDPN. Differences between groups were evaluated by the chi-squared, Wilcoxon, or Fisher's exact test. Binary logistic regression analysis was performed to determine the independent risk factors for sDPN. Receiver operating characteristic (ROC) curves were constructed, and the areas under curves (AUCs) were detected. Among 311 asymptomatic patients with T2DM, 142 (45.7%) with abnormal nerve conduction were diagnosed with sDPN. Patients with sDPN significantly differed from those without diabetic peripheral neuropathy (DPN) in age, history of hypertension, duration of diabetes, anemia, neutrophil-to-lymphocyte ratio, fasting C-peptide level, serum creatinine level, and albuminuria (all p<0.05). Furthermore, the duration of diabetes (odds ratio [OR]: 1.062, 95% confidence interval [CI]: 1.016-1.110), fasting C-peptide level (OR: 2.427, 95% CI: 1.126-5.231), and presence of albuminuria (OR: 2.481, 95% CI: 1.406-4.380) were independently associated with the development of sDPN (all p<0.05). The AUCs for fasting C-peptide level, duration of diabetes, and the two factors combined were 0.6229 (95% CI: 0.5603-0.6855, p=0.0002), 0.6738 (95% CI: 0.6142-0.7333, p<0.0001), and 0.6808 (95% CI: 0.6212-0.7404, p<0.0001), respectively. For patients with T2DM and longer duration of diabetes, lower fasting C-peptide levels, and presence with albuminuria, the risk for developing DPN is higher even if they have no clinical signs or symptoms. Identifying potential risk factors for the development of sDPN and effectively controlling them early are critical for the successful management of DPN.

UI MeSH Term Description Entries

Related Publications

Li Gao, and Jiexing Qin, and Ying Chen, and Wenqun Jiang, and Desheng Zhu, and Xiajun Zhou, and Jie Ding, and Huiying Qiu, and Yan Zhou, and Qing Dong, and Yangtai Guan
February 2012, Diabetes & metabolism journal,
Li Gao, and Jiexing Qin, and Ying Chen, and Wenqun Jiang, and Desheng Zhu, and Xiajun Zhou, and Jie Ding, and Huiying Qiu, and Yan Zhou, and Qing Dong, and Yangtai Guan
February 2010, Indian journal of medical sciences,
Li Gao, and Jiexing Qin, and Ying Chen, and Wenqun Jiang, and Desheng Zhu, and Xiajun Zhou, and Jie Ding, and Huiying Qiu, and Yan Zhou, and Qing Dong, and Yangtai Guan
June 2017, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban,
Li Gao, and Jiexing Qin, and Ying Chen, and Wenqun Jiang, and Desheng Zhu, and Xiajun Zhou, and Jie Ding, and Huiying Qiu, and Yan Zhou, and Qing Dong, and Yangtai Guan
January 2024, Diabetes research and clinical practice,
Li Gao, and Jiexing Qin, and Ying Chen, and Wenqun Jiang, and Desheng Zhu, and Xiajun Zhou, and Jie Ding, and Huiying Qiu, and Yan Zhou, and Qing Dong, and Yangtai Guan
December 2006, Acta neurologica Scandinavica,
Li Gao, and Jiexing Qin, and Ying Chen, and Wenqun Jiang, and Desheng Zhu, and Xiajun Zhou, and Jie Ding, and Huiying Qiu, and Yan Zhou, and Qing Dong, and Yangtai Guan
July 2017, Diabetes research and clinical practice,
Li Gao, and Jiexing Qin, and Ying Chen, and Wenqun Jiang, and Desheng Zhu, and Xiajun Zhou, and Jie Ding, and Huiying Qiu, and Yan Zhou, and Qing Dong, and Yangtai Guan
December 2020, Experimental and therapeutic medicine,
Li Gao, and Jiexing Qin, and Ying Chen, and Wenqun Jiang, and Desheng Zhu, and Xiajun Zhou, and Jie Ding, and Huiying Qiu, and Yan Zhou, and Qing Dong, and Yangtai Guan
September 2021, The Journal of international medical research,
Li Gao, and Jiexing Qin, and Ying Chen, and Wenqun Jiang, and Desheng Zhu, and Xiajun Zhou, and Jie Ding, and Huiying Qiu, and Yan Zhou, and Qing Dong, and Yangtai Guan
October 2015, Medicine,
Li Gao, and Jiexing Qin, and Ying Chen, and Wenqun Jiang, and Desheng Zhu, and Xiajun Zhou, and Jie Ding, and Huiying Qiu, and Yan Zhou, and Qing Dong, and Yangtai Guan
November 2014, Journal of diabetes investigation,
Copied contents to your clipboard!